cancer drug
cancer drug

Revolutionary Munich Company Doses First Patient with Groundbreaking Cancer Treatment
BIOT
📢 Tubulis from Munich doses first patient with its ADC candidate TUB-040 targeting NaPi2b antigen in ovarian and lung cancer. 🧪

Firefly Raises $94 Million to Revolutionize Cancer Treatment
BIOT
🔥 Firefly secures $94m 💼 to develop antibody conjugates ⚡️ for precision medicines targeting cancer and other diseases. 🌍

Groundbreaking Cancer Drug Shows Remarkable Results
BIOT
Exciting news! Vidac Pharma reports preclinical success for cancer drug VDA-1275, showing increased efficacy and immune response. 🚀💊🔬





